Mechanism underlying endothelium-dependent relaxation by 2-methylthio-ADP in monkey cerebral artery.
We recently reported endothelium-dependent relaxation caused by nucleotides in the non-human primate cerebral artery. Here, we investigated the endothelium-dependent, nitric oxide- and prostanoid-independent relaxation induced by 2-methylthio-ADP (2MeSADP) in monkey cerebral artery. Mechanical responses of isolated monkey cerebral arteries to the agents were isometrically recorded. In endothelium-intact arterial strips treated with indomethacin plus N(G)-nitro-L-arginine and partially contracted with prostaglandin F(2α), 2MeSADP (1 nM - 10 µM) induced concentration-dependent relaxation that was abolished by removal of endothelium but was not influenced by either carboxy PTIO or 18α-glycyrrhetinic acid. The 2MeSADP-induced relaxation was inhibited by MRS2179 and U73122. The relaxation was markedly suppressed by exposure of the strips to high K(+) media, but was not affected by glibenclamide. Combination of charybdotoxin plus apamin markedly suppressed the relaxation, whereas iberiotoxin partially attenuated it. Relaxation induced by 2MeSADP was inhibited by arachidonyl trifluoromethyl ketone, ketoconazole, and 14,15-epoxyeicosa-5(Z)-enoic acid. The inhibitors that affected the 2MeSADP-induced relaxation did not influence relaxation caused by sodium nitroprusside or forskolin. These findings indicate that 2MeSADP elicits 'endothelium-derived hyperpolarizing factor (EDHF)-type' relaxation via stimulation of endothelial P2Y(1) receptors in monkey cerebral artery. Furthermore, phospholipase A(2), cytochrome P450-derived epoxyeicosatrienoic acids and Ca(2+)-activated K(+) channels appear to be involved in the relaxation.
Geddawy
Ayman
A
Department of Pharmacology, Shiga University of Medical Sciences, Japan.
Shimosato
Takashi
T
Tawa
Masashi
M
Imamura
Takeshi
T
Okamura
Tomio
T
D000244:Adenosine Diphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D001030:Apamin / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology; D001120:Arginine / Q000494:pharmacology; D001685:Biological Factors / Q000502:physiology; D002536:Cerebral Arteries / Q000187:drug effects* / Q000502:physiology; D018999:Charybdotoxin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D008251:Macaca; D008297:Male; D009569:Nitric Oxide / Q000502:physiology; D009599:Nitroprusside / Q000494:pharmacology; D013873:Thionucleotides / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology*
D001095:Arachidonic Acids; D001685:Biological Factors; D013873:Thionucleotides; C067410:endothelium-dependent hyperpolarization factor; C081565:arachidonyltrifluoromethane; D018999:Charybdotoxin; C119129:18alpha-glycyrrhetinic acid; D009599:Nitroprusside; D001030:Apamin; D009569:Nitric Oxide; C002480:methylthio-ADP; D000244:Adenosine Diphosphate; D001120:Arginine; D006034:Glycyrrhetinic Acid